Status:
COMPLETED
Anesthesia Management of Coronary Artery Bypass Surgery and Inflammatory Biomarkers
Lead Sponsor:
Ankara City Hospital Bilkent
Conditions:
Coronary Artery Disease
Postoperative Complications
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to evaluate effect of total intravenous anesthesia or inhalation anesthesia on inflammatory biomarkers in coronary artery bypass surgery and their relationship ...
Detailed Description
This study is planned to be a prospective observational clinical study. Patients who will undergo on-pump coronary artery bypass surgery, meet the eligibility criteria and agree to participate in the ...
Eligibility Criteria
Inclusion
- On-pump bypass surgery
- Del-Nido cardioplegia used in operation
- ASA (American Society of Anesthesiologists) II- III patients
Exclusion
- Patients with active malignancy
- Diagnosed with systemic inflammatory disease or autoimmune disease
- Chronic liver and kidney disease
- History of cerebrovascular disease within 6 months
- EF (Ejection Fraction) \< 45%
- Non-cooperative or patients who do not agree to participate in the study
Key Trial Info
Start Date :
January 8 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2024
Estimated Enrollment :
228 Patients enrolled
Trial Details
Trial ID
NCT06209437
Start Date
January 8 2024
End Date
June 1 2024
Last Update
June 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara city hospital bilkent
Ankara, Çankaya, Turkey (Türkiye), 06800